These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31243084)

  • 1. Interaction between Antibiotic Resistance, Resistance Genes, and Treatment Response for Urinary Tract Infections in Primary Care.
    Ho HJ; Tan MX; Chen MI; Tan TY; Koo SH; Koong AYL; Ng LP; Hu PL; Tan KT; Moey PKS; Koh EYL; Wong CS; Lye DC; Tan NC
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31243084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children.
    Calzi A; Grignolo S; Caviglia I; Calevo MG; Losurdo G; Piaggio G; Bandettini R; Castagnola E
    Eur J Pediatr; 2016 Sep; 175(9):1219-1225. PubMed ID: 27558493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe.
    Guyomard-Rabenirina S; Malespine J; Ducat C; Sadikalay S; Falord M; Harrois D; Richard V; Dozois C; ; Breurec S; Talarmin A
    BMC Microbiol; 2016 Jun; 16(1):121. PubMed ID: 27342199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible
    Dunne MW; Puttagunta S; Aronin SI; Brossette S; Murray J; Gupta V
    Microbiol Spectr; 2022 Feb; 10(1):e0235921. PubMed ID: 35138150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic treatment failure of uncomplicated urinary tract infections in primary care.
    Koh SWC; Ng TSM; Loh VWK; Goh JC; Low SH; Tan WZ; Wong HC; Durai P; Sun LJ; Young D; Tambyah PA
    Antimicrob Resist Infect Control; 2023 Aug; 12(1):73. PubMed ID: 37528415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care.
    Wong CKM; Kung K; Au-Doung PLW; Ip M; Lee N; Fung A; Wong SYS
    PLoS One; 2017; 12(5):e0177266. PubMed ID: 28486532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients.
    Hatzaki D; Poulakou G; Katsarolis I; Lambri N; Souli M; Deliolanis I; Nikolopoulos GK; Lebessi E; Giamarellou H
    BMC Infect Dis; 2012 Sep; 12():228. PubMed ID: 23009290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with community-acquired urinary tract infections among adults attending assessment centre, Mulago Hospital Uganda.
    Kabugo D; Kizito S; Ashok DD; Graham KA; Nabimba R; Namunana S; Kabaka MR; Achan B; Najjuka FC
    Afr Health Sci; 2016 Dec; 16(4):1131-1142. PubMed ID: 28479906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options.
    Origüen J; Fernández-Ruiz M; López-Medrano F; Ruiz-Merlo T; González E; Morales JM; Fiorante S; San-Juan R; Villa J; Orellana MÁ; Andrés A; Aguado JM
    Transpl Infect Dis; 2016 Aug; 18(4):575-84. PubMed ID: 27373698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
    Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
    Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.
    Eltai NO; Al Thani AA; Al-Ansari K; Deshmukh AS; Wehedy E; Al-Hadidi SH; Yassine HM
    Antimicrob Resist Infect Control; 2018; 7():90. PubMed ID: 30069306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study.
    Stewardson AJ; Vervoort J; Adriaenssens N; Coenen S; Godycki-Cwirko M; Kowalczyk A; Huttner BD; Lammens C; Malhotra-Kumar S; Goossens H; Harbarth S; ;
    Clin Microbiol Infect; 2018 Sep; 24(9):972-979. PubMed ID: 29331548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical treatment of urinary tract infections: how rational are our guidelines?
    O'Grady MC; Barry L; Corcoran GD; Hooton C; Sleator RD; Lucey B
    J Antimicrob Chemother; 2019 Jan; 74(1):214-217. PubMed ID: 30295780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study.
    Kothari A; Sagar V
    J Infect Dev Ctries; 2008 Oct; 2(5):354-8. PubMed ID: 19745502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant
    Amladi AU; Abirami B; Devi SM; Sudarsanam TD; Kandasamy S; Kekre N; Veeraraghavan B; Sahni RD
    Indian J Med Res; 2019 Feb; 149(2):185-191. PubMed ID: 31219082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs.
    Kotb DN; Mahdy WK; Mahmoud MS; Khairy RMM
    BMC Infect Dis; 2019 Nov; 19(1):979. PubMed ID: 31752702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterization of Extended-Spectrum β-Lactamase
    Shash RY; Elshimy AA; Soliman MY; Mosharafa AA
    Am J Trop Med Hyg; 2019 Mar; 100(3):522-528. PubMed ID: 30594263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.